Leaflet ETOMIDAT-LIPURO 2mg / ml injection emulsion


Indicated for: general anesthesia; procedural sedation

Route of administration: injectable

Substance: etomidate (general anesthetic)

ATC: N01AX07 (Nervous system | Anesthetics, general | Other general anesthetics)

Etomidate is an anesthetic medication used for the rapid induction of general anesthesia, especially in emergency procedures or short surgical interventions. It acts quickly on the central nervous system, causing loss of consciousness and the muscle relaxation needed for medical procedures.

Etomidate is administered intravenously under strict medical supervision by specialized personnel. The dose is adjusted according to the patient's weight, age, and general condition to ensure the safety and effectiveness of anesthesia.

Adverse effects may include involuntary muscle movements, temporary lowering of blood pressure, nausea, or vomiting after awakening. In rare cases, allergic reactions or adrenal dysfunction may occur, which is why careful monitoring is essential.

Etomidate is a safe and effective option for inducing general anesthesia, being preferred in situations where rapid and controlled action is required.

General data about ETOMIDAT-LIPURO 2mg / ml

  • Substance: etomidate
  • Date of last drug list: 01-05-2026
  • Commercial code: W06958001
  • Concentration: 2mg / ml
  • Pharmaceutical form: injection emulsion
  • Packing volume: 10 ml
  • Product type: original
  • Price: 181.11 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: B. BRAUN MELSUNGEN AG - GERMANIA
  • Holder: B. BRAUN MELSUNGEN AG - GERMANIA
  • Number: 5185/2012/01
  • Shelf life: 2 years